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Background: Traditional echocardiographic methods like left ventricular ejection fraction(EF) and wall motion
scoring (WMS) and new methods like speckle tracking (ST) based 2D strain carry important prognostic information
in acute coronary syndrome (ACS) patients. Parameters from tissue Doppler imaging (TDI), with its high time
resolution, may further increase the prognostic value. Peak systolic velocity (PSV) of the basal segments of the left
ventricle from TDI is a robust and user independent parameter. The aim was to investigate the prognostic value of
PSV compared to EF, WMS, 2D strain and E/e'.
Methods: Echocardiographic images were collected and post processed in 227 ACS patients. Additional clinical
data was prospectively gathered and patients were followed for 3-5 years regarding the combined endpoint of
death or re-admission due to ACS or heart failure.
Results: The combined endpoint occurred in 85 (37%) patients. Those with an event had lower median PSV than
those without (4,4 cm/s) vs. (5,3 cm/s), (p<0.001). In a ROC analysis, the AUC was larger for PSV (0.75) than for
EF (0.68), WMS (0.63), 2D strain (0.67) and E/e'(0.70). The combined endpoint increased with decreasing PSV. When
adjusting for differences in baseline characteristics in a COX-regression model, PSV remained independently
associated with outcome where the others did not. PSV was also less sensitive to image quality with fewer values
missing or unacceptable for analysis.
Conclusion: Peak systolic velocity (PSV) is a robust measurement that seems to have a strong and independent
association with outcome compared to traditional echocardiographic measurements in ACS patients.
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Patients admitted to hospital because of an acute coro-
nary syndrome (ACS) constitute a heterogeneous popula-
tion with a varying risk of future cardiac events. To
identify high-risk patients who may benefit from an inten-
sified treatment strategy and low-risk patients who may
benefit from a more conservative approach and early dis-
charge, risk stratification is important. Traditionally,* Correspondence: carl.westholm@karolinska.se
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distribution, and reproduction in any mediumechocardiographic measurements of left ventricular sys-
tolic function, such as ejection fraction (EF) and wall mo-
tion scoring (WMS), have been considered as essential in
this process [1,2] However both EF and WMS are limited
by being highly user dependent with a rather long learning
curve and poor reproducibility [3,4]. Subsequent studies
have introduced the diastolic echocardiographic param-
eter E/e' -ratio, that reflects the filling pressure of the left
ventricle [5] as a prognostic parameter with incremental
value to EF and WMS [6,7]. It has also been shown that
this parameter adds complementary prognostic value to
biochemical markers such as type B natriuretic peptide
[8,9] after acute myocardial infarction (AMI) [10,11].tral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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strain obtained from two-dimensional (2D) echocardiog-
raphy based speckle tracking or tissue doppler imaging
(TDI) has also been shown to add prognostic value to
the traditional parameters [12,13]. This measurement de-
rived from speckle tracking or TDI is less user dependent
and more easily accessible compared to 2D-derived
EF, WMS and E/e' although problems with feasibility
remains [14-17].
Whereas systolic values of parameters like global sys-
tolic strain and the diastolic parameter E/e'-ratio have
been shown useful for risk stratification in ACS patients,
less is known about the prognostic value of systolic tis-
sue velocities in this group of patients.
Peak systolic velocity (PSV) of the basal segments of
the left ventricle from TDI is a feasible and relatively
user independent measure (Figure 1). Tissue Doppler
imaging has a higher time resolution than 2D-speckle
tracking echocardiography and can therefore register
processes not visible for the human eye or for speckle
tracking [18,19]. The aim of this study was to investigate
the prognostic value and feasibility of PSV compared to
both traditional parameters, such as EF, WMS, E/e'-ratio
and more recent such as 2D-strain.
Method
Study population
The study included patients admitted to the coronary
care unit at Karolinska University Hospital, Huddinge,Figure 1 How the peak systolic velocity (PSV) information is acquired
of the left ventricle and the corresponding tissue velocity is showed in the
below in the picture. The time is on the x-axis and velocity in cm/s on thebetween August 2006 and January 2008 with a clinical
diagnosis of ACS including unstable angina pectoris, ST
elevation myocardial infarction and non ST elevation
myocardial infarction. The patients were consecutively
included except for temporary interruptions of the study
due to high work load at the coronary care unit. Cardiac
comorbidities such as valvular disease or arrhythmia
were not reasons for exclusion. All patients underwent
clinical assessment including clinical history, physical
examination, standard 12-lead ECG, ECG-monitoring
and serial measurement of biochemical cardiac markers
up to 9–12 hours after admission. All other examina-
tions and treatments were left to the discretion of the in-
dividual cardiologist. Clinical data were prospectively
collected and entered into a database. An acute MI was
defined according to current guidelines [20].
The combined end point was death from any cause,
MI and rehospitalisation for heart failure. All in-hospital
events were registered in the study database. Only new
MIs occurring more than 24 hours after admission were
considered as events. Out of hospital, information about
death and need for readmission because of MI or heart
failure was obtained by merging the database with the
National Death Registry, which includes information of
the vital status of all Swedish citizens, and the National
Patient Registry, which includes diagnoses on all patients
hospitalized in Sweden.
All patients received oral and written information about
the study and written informed consent was obtained. The region of interest (ROI) is manually placed in the basal segments
graph to the right where you can register the PSV guided by the ECG
y-axis.
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according to the principles of the Declaration of Helsinki
and was approved by the local ethics committee.
Laboratory analyses
N-terminal pro B-type natriuretic peptide (NT-proBNP)
was determined 24 hours after admission by using the
assay from Roche Diagnostics on a Modular Analytics
E170. The analytical range extends from 20 to 35000 ng/L.
Plasma creatinine was analysed on admission. Estimated
glomerular filtration rate (eGFR) was calculated by using
the Cockcroft-Gault formula [21].
Echocardiographic acquisition and analyses
All echocardiography data was collected during the first
days (median (25th-75th percentile): 3(2–4)) of admission
according to the local standard clinical protocol at that
time on Karolinska University Hospital by the cardiologist
or cardiac technician on duty that day. The images, in-
cluding 2D, TDI and spectral Doppler, were collected with
a GE Vingmed vivid7 ultrasound machine with a M3S or
M4S transducer and standard installed software.
The images were analyzed using a dedicated worksta-
tion (EchoPAC, GE Healthcare, Horten Norway) by a
well-trained cardiologist (CW) blinded to baseline data
and subsequent outcome.
Ejection fraction was measured according to current
EAE/ASE recommendations [22] using the biplane
Simpson method of discs from outlining the endocardial
border in the apical 4-, and 2-chamber views.
Wall motion score was determined as the mean value
of an 18 segment model from the three apical views,
where each segment was given a score of 1–3, in which
1 represented normokinesia, 2 indicated hypokinesia,
and 3, akinesia.
Two dimensional-strain was derived from apical 2D
images using the EchoPAC software. Global 2D strain
was calculated as the mean of the regional longitudinal
strain of the 18 different segments and was calculated if
the strain was measurable in at least 12 segments. The
Automatic tracking was visually controlled and manually
corrected if needed. Strain information can also be
obtained from TDI but in this material the apical projec-
tions of TDI did often not include the apical segments
and quite often also just parts of the midventricular seg-
ment and therefore we concluded that Strain from TDI
could not be obtained in this study.
E/e' was calculated from the E-wave of the mitral in-
flow to the LV measured by pulsed Doppler and e' was
measured from the four chamber TDI image as the
mean of the septal and lateral maximum diastolic
velocities.
PSV was measured from TDI images, as illustrated in
Figure 1. The global PSV value was defined as the meanof the velocities from the 6 different basal segments of
the left ventricle. We excluded velocity peaks from the
isovolumetric phases with end systole defined by the
closing of the aortic valve in the three chamber projec-
tion. As mentioned above, the images were collected by
various sonographers and physicians during the inclu-
sion without standardized frame rate which therefore
varied between 100 and 150 frames/s between patients.
As the longitudinal velocities are a more global param-
eter compared to Strain with co variation between adja-
cent segments we calculated PSV if the basal velocity
was measureable in at least 2 of 6 segments. To confirm
that assumption the correlation between the PSV only
from the septal and lateral wall and that of PSV as mean
from all basal segments was examined.
Image quality was registered using a four-grade scale,
as well as the reason for a missing value (non existing
image or too poor quality to allow analysis).
To investigate the interobserver variability, another
well-trained cardiologist (AS) measured PSV on 20 ran-
domly chosen patients. The variability was evaluated by
calculating the Coefficient of Variation (CV) using the
formula “CV = Standard deviation / expected return”
where the expected return is the mean of all the mea-
surements by both readers, and the standard deviation
is of the differences between the paired readings. As
PSV was our main focus in this study we did not inves-
tigate the CV of other parameters that has already been
investigated [16].
Statistical analysis
Continuous data are presented as medians with inter-
quartile range (IQR) and categorical data are presented
with frequencies and percent. When analyzing differ-
ences between groups the Mann Whitney-test was used
for continuous variables and Chi2-test for categorical
variables. To compare the prognostic value regardless of
chosen cut off-value, we used receiver operating charac-
teristics (ROC) analyses expressing prognostic value as
area under curve (AUC) with 95% confidence interval
(CI) and significance tested according to Hanley and
McNeil [23] To illustrate the timing of events, Kaplan
Meier curves were generated. Correlations were evalu-
ated with Spearman’s rho.
To identify which echocardiographic parameters were
independent predictors of outcome we used Cox-
regression analyses, adjusting for other variable well
known to be associated with outcome (age, gender, dia-
betes, hypertension and previous heart failure) in three
different models. In model 1 each tested echocardio-
graphic parameter was entered one by one together with
the above mentioned risk factors. In model 2 we also in-
cluded NT proBNP and eGFR among the risk factors to
adjust for. In model 3 we removed NT proBNP and
Table 1 Baseline characteristics (n = 227)
All No death, MI or HF Death, MI or HF
(n=227) (n= 142) (n=85)
Variables n (%) n (%) n (%) p
Demographics:
Age (median, 25th-75th perc.) 67 (59–77) 62 (56–74) 74 (63–80) <0,001
Men 172 (76) 111 (78) 61 (72) 0.276
Risk factors:
Hypertension 121 (53) 63 (44) 58 (68) <0.001
Diabetes Mellitus 51 (22) 29 (20) 22 (26) 0.340
Current smoker (missing n=6) 43 (19) 33 (23) 10 (13) 0.049
Previous cardiovascular disease:
Myocardial infarction 56 (25) 31 (22) 25 (30) 0.200
Heart Failure 19 (8) 2 (1) 17 (20) <0.001
Revascularization, PCI 33 (15) 23 (16) 10 (12) 0.359
Revascularization, CABG 10 (4) 4 (3) 6 (7) 0.132
Stroke 17 (7) 10 (7) 7 (8) 0.741
Laboratory measurements
NTproBNP 24 h (median, 25th-75th perc.) (n=189)) 724 (303–1887) 2300 (1030–26040) <0.001
eGFR (median, 25th-75th perc.) (n=220) 92 (72–116) 66 (40–96) <0.001
Index Diagnosis
Myocardial infarction 188 (83) 119 (84) 69 (81) 0.612
MI=Myocardial infarction, HF=Heart failure, eGFR=glomerular filtration rate.
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to adjust for. To evaluate whether early intervention
influenced the association between PSV and outcome,
coronary angiography and treatment with PCI or CABG
were also included in the models.Results
A total of 227 patients were included in the study. The
median follow up time was 53 (48–58) months. During
this period 85 (37%) patients reached the combined end-
point, among them 42 (19%) died, 48 (21%) had a MI
and 52 (23%) were readmitted because of heart failure.
Baseline characteristics, laboratory data and final diag-
noses at the index event in all patients and in those withTable 2 Echocardiographic measurements
All No dea
(n=227) (n
Variables median (25th-75th perc) median
PSV 4.9 (4.2-5.8) 5.3
EF 49 (41–56) 52
WMS 1.0 (1.0-1.3) 1.26
Global 2D-Strain −14 (−18- -9.8) −15
E/e'-ratio 13.4 (10.1-17.6) 13.2
MI=Myocardial infarction, HF=Heart failure, PSV=peak systolic velocity, EF=ejectionand without a subsequent event are listed in Table 1. Pa-
tients with an event were older and had more often
hypertension and a previous history of heart failure.
They also had a higher level of NT-proBNP and a lower
eGFR. Coronary angiography was performed in 192 pa-
tients, of which 109 and 25 underwent percutaneous
coronary intervention (PCI) and coronary bypass surgery
(CABG), respectively.Echocardiographic acquisition and measurements
Peak systolic velocity could be measured in all except 3
(1%) patients, whereas EF Simpson and WMS could not
be assessed in 19 (8%) and 9 (4%) patients, respectively.
2D-strain could not be obtained in 41 (18%) of theth, MI or HF Death, MI or HF
= 142) (n=85)
(25th-75th perc) median (25th-75th perc) p
(4.7-6.0) 4.4 (3.6-5.0) <0.001
(45–58) 45 (35–52) <0.001
(1.09-1.16) 1.29 (1.21-1.36) <0.001
(−19- -11) −11 (−16.8- -5.0) <0.001
(12.3-14.2) 18.4 (16.1-20.8) <0.001
fraction, WMS=Wall motion scoring.





Global 2D-Strain 0.67 (0.58-0.75)
E/e'-ratio 0.70 (0.62-0.77)
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(12%). The results of the echocardiographic measurements
are listed in Table 2. When assessing the interobserver
variability between two observers regarding PSV measure-
ments the CV was 5.9%. The correlation (Spearman’s rho)
between global PSV calculated from 6 basal segments and
PSV calculated from only the septal and lateral segment
was 0.91.Prognostic value of peak systolic velocity in comparison
to other echocardiographic data
Patients with an combined event had lower median PSV
than those without (4,4 cm/s) vs. (5,3 cm/s), (p<0.001).
These groups also differed significantly regarding EF
Simpson, WMS, strain and E/e'-ratio (Table 2). In ROC
analyses, the AUC (Area under curve) was larger forFigure 2 Combined endpoint (death, myocardial infarction or readmiPSV than for the other parameters but the differences
did not reach statistical significance (Table 3). When pa-
tients were divided into tertiles according to the PSV
measurements the long term risk of subsequent cardiac
events increased with decreasing PSV (Figure 2). The as-
sociation between PSV and outcome was apparent for all
individual endpoints (Table 4).
Independent predictors of outcome
All tested echocardiographic parameters except 2D-
strain remained independently associated with outcome
when these variables one at the time were adjusted for
age, gender, diabetes, hypertension and previous heart
failure (Table 5, model 1). When patients in the third
tertile according to PSV (>5.5 cm/s) were used as refer-
ence the HR(95%CI) increased to 1.65 (0.80-3.37)
p=0.169, and 3.16 (1.58-6.35) p=0.001 in the second and
first tertile, respectively. In model 2 where NT-proBNP
and eGFR were added to the model, only PSV, and E/e'
and remained independent predictors of outcome
(Table 5, model 2). When including PSV in the model,
PSV was the only echocardiographic parameter inde-
pendently associated with outcome (Table 5, model 3).
When we included intervention with PCI or CABG in
the model, PSV remained significantly associated with
outcome, (HR(95%) 0.66 (0.51-0,84), p=0.001).ssion because of heart failure) in relation to PSV measurement.
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This study demonstrates that PSV can be measured in
most patients with a low interobserver variability and
may even be a better predictor of outcome than both
traditional echocardiographic measurements of left ven-
tricular function, such as EF, WMS and E/e'-ratio and
more recent deformation parameters, such as myocardial
strain in ACS patients.
The aim of this study was to test PSV in a real world
setting. We therefore included consecutive unselected
ACS patients and all images were acquired as in the
clinical routine. In the univariable analyses, the median
PSV value was lower in those with than in those without
a subsequent cardiac event. When categorizing patients
according PSV values, a low-, intermediate- and high-
risk group could be identified with a 5-year cumulative
risk of death, MI or readmission because of heart failure
of 17%, 32% and 64%, respectively. Even after adjusting for
differences in well-known predictors of outcome (includ-
ing natriuretic peptides and estimates of kidney function),
there was a strong association between PSV and outcome,
with a 1.4 fold increased risk of the combined endpoint
for every unit decrease in PSV.Table 5 Cox-regression analysis
Parameter Model 1. Model 2.





24 h and eG
HR (95%CI) p HR (95%CI)
PSV 0.65 (0.51-0.82) <0.001 0.71 (0.54-0.9
EF 0.97 (0.95-0.99) 0.006 0.98 (0.96-1.0
WMS 2.09 (1.06-4.15) 0.035 1.52 (0.71-3.2
Global 2D Strain 1.03 (0.99-1.07) 0.003 1.04 (0.96-1.0
E/e' 17.97 (2.24-144.01) 0.007 20.0 (2.31-17When the prognostic value of PSV was compared with
that of other echocardiographic parameters in a ROC
analysis, PSV had the largest AUC although the differ-
ences were not statistical significant. When the echocar-
diographic parameters were tested one by one in a
regression model including well-known predictor of out-
come, only PSV and E/e'-ratio remained associated with
outcome, whereas EF, WMS and strain failed to independ-
ently predict outcome. Finally, when PSV was included in
the model, none of the other echocardiographic parame-
ters carried any additional prognostic information.
The predictive value of different echocardiographic pa-
rameters may vary in different patient populations.
Wang et al. [6] demonstrated a better prognostic value
for both é, PSV and E/e' than for EF and WMS. In that
study e' was the strongest predictor of cardiac death al-
though PSV and E/e' also were strong predictors of car-
diac death. However, the study by Wang and co-workers
included patients with a broad spectrum of heart disease
and only 16% had ischemic heart disease. The fact that
the diastolic parameter e' was demonstrated to have a
higher prognostic value than PSV might be explained by
a relatively small proportion of patients having ischemic
heart disease and a larger proportion of patients having
heart failure. In such a population the proportion of
patients with high filling pressure is expected to be
higher than in our study population, which included
ACS patients with predominantly normal or only mildly
depressed EF.
Our study does not only confirm but also extends pre-
vious findings showing that E/e' has an incremental
prognostic value to that of natriuretic peptides [8,9].
Somewhat unexpectedly 2D-strain was not better to pre-
dict outcome than traditional measurements of systolicModel 3.
r the same factors
plus NT proBNP
FR
Adjusted for the same as model 1
plus PSV. The corresponding
results for PSV is also presented
for each parameter HR (95%CI)
p HR (95%CI) p
3) 0.013 ———————————
———————————
0) 0.070 0.99 (0.96-1.01) 0.227
PSV 0.68 (0.52-0.90) 0.007
4) 0.280 0.95 (0.41-2.22) 0.915
PSV 0.61 (0.46-0.82) 0.001
5) 0.037 1.02 (0.98-1.06) 0.249
PSV 0.67 (0.50-0.90) 0.032
4.4) 0.007 6.90 (0.740-64.27) 0.090
PSV 0.70 (0.54-0.91) 0.008
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earlier studies in the field. In a cohort of 649 ACS pa-
tients Antoni and co-workers showed that both strain
and strain rate were superior to the traditional parame-
ters, EF and WMS, to predict 1-year outcome [16] and
similar finding were made by Bertoni and co-workers
but in a population with chronic ischemic heart disease
[24]. In our study, we could not confirm a superiority of
deformation parameters in comparison to EF and WMS.
Clearly, the operator’s skills and experience, and their
compliance to strict protocols are important determi-
nants of the quality of echocardiographic examinations.
It is important to note that the images in our study was
collected from routine clinical echocardiography not al-
ways of highest quality, but still sufficient for analyzing
PSV in a very large proportion of the patients, whereas
in the study of Antoni et al. and Bertoni et al., all exams
were performed within a dedicated laboratory with great
experience of conducting studies and using deformation
analysis. Still, even if a technique is good in the hands of
experts in specialized centers, it can be problematic in
the more generalized everyday clinical situation if the
demand for technical skill is too high [25].
Therefore, the simplicity of PSV must be regarded as a
great advantage, which can be an important determinant
to why PSV in our study is superior to the other param-
eters. Another advantage is the fact that the method
seems robust and insensitive to poor image quality with
a low interobserver variability and low number of miss-
ing values. Thus the results of this study indicates that
PSV could be superior to other parameters as a clinical
routine method outside a core laboratory to predict out-
come. Furthermore the strong correlation (0.91) between
global PSV from all 6 basal segments and PSV from only
septal and lateral wall indicates that the use of only one
projection and two measurement might be as predictive
as the global PSV which would further simplifiy the
method.
The present study has some limitations. The sample
size was rather small. Thus, lack of significant differ-
ences may still be caused by lack of power to detect such
differences and our findings need to be confirmed in
larger studies. Although interobserver variability was
assessed for PSV in a subgroup of patients and all analyses
were performed according to a protocol, only one person
performed the echocardiographic analyses. Due to the
clinical setting and image quality, strain rate was not in-
cluded in this study. Strain rate is the derivate of strain
and therefore it is reasonable to believe that the variability
and number of missing values would be even higher com-
pared to strain.
This study used a prespecified combined endpoint. Al-
though PSV was significantly associated with all individ-
ual endpoints, the underlying mechanisms for theseassociations may differ. Systolic LV-dysfunction is known
to cause both heart failure and death, whereas the asso-
ciation between systolic LV-dysfunction and subsequent
risk of new MI may be explained by the association be-
tween systolic LV-dysfunction and severity of coronary
artery disease.
In conclusion, PSV seems to be a robust and easily
obtained echocardiographic measurement that may be
very useful for risk stratifying ACS patients.
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